23 January 2017 - Advertising and public affairs campaign will convene national health care dialogue, educational events and stakeholder engagements across the country.

The Pharmaceutical Research and Manufacturers of America (PhRMA) today launched a national, multi-year advertising and public affairs initiative on behalf of America’s biopharmaceutical companies. The campaign, GOBOLDLY, will showcase the industry’s unsung heroes driving cutting-edge advances in science and highlight the tremendous opportunity that exists to tackle our most complex and devastating health conditions.

“Thanks to the tireless work of biopharmaceutical researchers and scientists, we have entered a new era of medicine that is transforming the way we prevent and treat disease. This campaign spotlights their perseverance and unwavering commitment to American patients for whom we all work,” said Stephen J. Ubl, president and chief executive officer of PhRMA. “We will also be convening events with stakeholders all across the country to discuss ways we can work together to make our health care system more responsive to the needs of patients.”

Read PhRMA press release